AI designs a protein drug from scratch to take on gastric cancer's "cold tumors": RFdiffusion builds a CLDN18.2 T-cell engager
A team at the First Affiliated Hospital of Nanjing Medical University reports in the Journal of Translational Medicine that the RFdiffusion protein design system generated a CLDN18.2-targeting T-cell engager from scratch, offering a new approach to gastric cancer immunotherapy.